FindTrial
Sign In

High-Flow Nasal Oxygenation in Obstructive Sleep Apnea Patients During Apnea

High-Flow Nasal Oxygen Improves Safe Apnea Time in Obstructive Sleep Apnea Patients Undergoing General Anesthesia: A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050517
Enrollment
Unknown
Registered
2021-08-28
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea Patients

Interventions

Experimental group:High flow nasal oxygen (60 l) under GA
Control group:Standard oxygen under GA

Sponsors

Beijing Tongren Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged > 18 years; 2. ASA I-III; 3. Elective tracheal intubation under general anesthesia; 4. Diagnosed with sleep apnea syndrome.

Exclusion criteria

Exclusion criteria: 1. Patients with chronic respiratory diseases; 2. In the state of oxygen inhalation, the oxygen saturation is less than 98%; 3. Predictable difficulty in intubation; 4. Uncontrolled hypertension; 5. Ischemic cardiomyopathy; 6. Congestive heart failure; 7. Increased intracranial pressure; 8. Uncontrolled gastroesophageal reflux disease; 9. Known allergy to anesthetics; 10. Patients with nasopharyngeal blockage cannot use high-flow devices.

Design outcomes

Primary

MeasureTime frame
safe apnea time;—

Secondary

MeasureTime frame
Minimum blood oxygen saturation;Plateau end-tidal carbon dioxide;Time to regain baseline blood oxygen saturation;percutaneous carbon dioxide monitoring;—

Countries

China

Contacts

Public ContactWang Guyan

Beijing Tongren Hospital

guyanwang2006@163.com+86 13910985139

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026